Downregulation of ACSL5 could be an independent prognostic factor for early recurrence of colorectal cancer [69], meanwhile dysregulated ALAS2 expression was related to the risk of acute myeloid leukemia [70]. The gene discussed is ALAS2; the disease is colorectal cancer.